When one considers areas of technological advancement and taking risks, typically the healthcare industry is considered to be an industry where it has always been recommended to play it closer to the chest. The risks associated to testing unmanned spacecrafts and self-driving vehicles have statistically been more acceptable than trying a dangerous form of treatment for an infectious disease mainly because a price cannot be put on a human life. Having said that, the significance of technological progress will have the greatest positive outcome if innovators and brilliant minds continue to create for the purpose of evolving the future of healthcare. We can’t just play it safe anymore. The world is becoming far too advanced for medical professionals not to take risks and invest in advancing how we take care of our patients.
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
As we’ve seen in recent months, one of the most lucrative commodities in modern times is big data. Companies will do almost anything to gain information about consumers so that they can better create to meet the growing demands of the public. Any level of insight into a person’s likes, dislikes, and personal preferences can give a company the upper hand in their industry.
As it relates to the field of medicine, experts believe that machine learning will be the guiding tech for the future of medical research and drug development. If medical systems can process large data sets and identify patients with higher success probabilities, medical professionals can better cater treatment options for patients.
Another significant technological advancement making waves across the healthcare industry is augmented reality. According to recent reports, the healthcare-based AR market is projected to be worth over $5 billion with over 3 million global users by 2025. It’s important to point out that no healthcare company has the bandwidth to tackle every issue facing their industry, but this is in no way an indication that there aren’t companies who’ve risen to the occasion.
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) is a Canadian publicly traded company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies to provide the best possible care solutions for their patients. As a leader in the healthcare industry, it was only a matter of time before Premier Health made a play to invest in augmented reality technology. The Company announced earlier this week that they are working with NexTech AR Solutions to explore bringing AR technology to its patient-centric healthcare app.
Per the details of the announcement, Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F)will collaborate with NexTech to to develop educational tools for healthcare professionals and patients alike through the use of augmented reality technology. The potential applications of AR in training medical professionals are endless because the tech creates an incredibly engaging and immersive educational experience. Imagine medical professionals being able to take their anatomical education one step further by being able to visually interact with a virtual representation of the human heart, as well as visually demonstrate to their patients exactly what is going on internally.
“At Premier Health we pride ourselves in being at the forefront of changes in healthcare, so we are thrilled to be a part of the future of healthcare by enabling state of the art technological advancements to our patient-centric telemedicine app. AR has the potential to revolutionize both the access to data and the delivery of healthcare. The technology will help doctors and patients alike – doctors will have access to the latest and most relevant information about their patients while patients can use AR for self-education and improving the quality of treatment they receive.”
–Dr. Essam Hamza, CEO of Premier Health
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 CASH for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam has been compensated an additional $100,000 by Premier Health Group to extend the period of coverage to June 1, 2019. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
